AzTrials
AzTrials

Ligament InjuryNCT04348253

Danish Multicenter Scapholunate Ligament Study

A study testing Berger and 3LT in people with Ligament Injury and Wrist Sprain, run by University of Aarhus at 2 sites in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Comparison of two surgical techniques commonly used for reconstruction of the scapholunate (SL) ligament. A randomized multicenter study. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Ligament Injury, Wrist Sprain
What is being tested?
Berger and 3LT
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesDenmark
Study dates
1 Aug 2018to 30 Apr 2033
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-60 years (both included).
  • Symptomatic SL instability (VAS score ³3, QDASH score ³ 20).
  • > 6 weeks since symptomatic hand trauma (chronic SL lesions).
  • SL gapping on radiographic stress views or SL gapping (³2mm) on static PA views.
  • Complete SL ligament lesion confirmed by wrist arthroscopy

Who cannot join

  • Geissler grade 1-3 SLL injury (evaluated by arthroscopy).
  • Concomitant complete luno-triquetral (LT) ligament injury (evaluated by arthroscopy).
  • Lesion of TFCC leading to DRUJ instability (evaluated by arthroscopy).
  • Radiocarpal or midcarpal arthritis evaluated by arthroscopy.
  • Previous fracture in carpus or intraarticular radius fracture with step off (³2 mm), disposing to posttraumatic arthritis.
  • Adverse effects after extra articular radial fractures (dorsal angulation ³10 grader).
  • Peroperatively non-reducible scaphoid flexion/SL gap.
  • Terminal illness or severe medical illness: ASA score higher than or equal to 3.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Janni K Thillemann, Dr contact

+45 28137303

teamjanni@gmail.com

Denmark2 sites, 2 recruiting
  • Aarhus University Hospital

    Aarhus, 8200

    Maiken Stilling, Professor

    Recruiting
  • Hospital Unit Vest

    Holstebro, 7500

    Janni K Thillemann, Dr, +4528137303, teamjanni@gmail.com

    Recruiting

Other trials in Denmark

About this study

Official title: Reconstruction of Chronic Scapholunate Ligament Injuries in the Wrist: A Randomized Controlled Trial Comparing The Berger Capsulodesis and Three-Ligament-Tenodesis (3LT)

Comparison of two surgical techniques commonly used for reconstruction of the scapholunate (SL) ligament. A randomized multicenter study.

Read the detailed description

This multicentre study aim to compare two surgical techniques commonly used for reconstruction of the scapholunate (SL) ligament. The investigators compare patient reported, clinical and radiological outcomes up to 10 years after treatment of complete dynamic or static but reducible SL ligament lesions. The participants are randomized to two treatments. Effect parameters before and after intervention are compared between groups.

Being tested
Berger, 3LT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BergerProcedure or surgery

    Treatment 1

  • 3LTProcedure or surgery

    Treatment 2

Study groups in NCT04348253
Study groupRoleWhat they receive
BergerActive comparatorBergers capsulodesis
Receives: Procedure: Berger
3LTActive comparatorThree ligament tenodesis
Receives: Procedure: 3LT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Disabilities of the Arm, Shoulder and Hand Score (QuickDash)

    points

    Measured: At all follow-ups (0-10 years)

Secondary outcomes (4)
  1. Grip-strength

    kg

    Measured: At all follow-ups (0-10 years)

  2. SL angle

    degrees

    Measured: At all follow-ups (0-10 years)

  3. The Patient-Rated Wrist Evaluation (PRWE) score

    points

    Measured: At all follow-ups (0-10 years)

  4. Wrist motion

    degrees

    Measured: At all follow-ups (0-10 years)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2020
  2. Study start1 Aug 2018
  3. Primary completion30 Apr 2023 (estimated)
  4. Study completion30 Apr 2033 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04348253
Sponsor's protocol ID
1-10-72-169-18
Status last verified
Mar 2020
First submitted
30 Mar 2020
Last updated
16 Apr 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Berger and 3LT in people with Ligament Injury and Wrist Sprain, run by University of Aarhus at 2 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Janni K Thillemann, Dr (+45 28137303, teamjanni@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Disabilities of the Arm, Shoulder and Hand Score (QuickDash) (time frame: At all follow-ups (0-10 years)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in